H.B. Fuller (NYSE:FUL) Price Target Cut to $60.00 by Analysts at JPMorgan Chase & Co.

H.B. Fuller (NYSE:FUL) had its price objective lowered by equities research analysts at JPMorgan Chase & Co. from $70.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s target price suggests a potential downside of 5.11% from the stock’s current price.

Other equities analysts also recently issued reports about the stock. Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. Citigroup dropped their price objective on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $84.20.

H.B. Fuller Price Performance

Shares of H.B. Fuller stock traded up $1.01 during trading on Friday, hitting $63.23. 43,223 shares of the stock traded hands, compared to its average volume of 410,880. The stock has a market cap of $3.45 billion, a price-to-earnings ratio of 19.49, a PEG ratio of 1.50 and a beta of 1.43. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.10. H.B. Fuller has a 52 week low of $60.96 and a 52 week high of $87.67. The firm’s fifty day moving average is $71.13 and its 200-day moving average is $76.89.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). H.B. Fuller had a net margin of 5.15% and a return on equity of 13.39%. The company had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. During the same period last year, the business posted $1.32 earnings per share. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. Research analysts expect that H.B. Fuller will post 3.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC raised its holdings in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after acquiring an additional 18,734 shares during the last quarter. Lord Abbett & CO. LLC boosted its stake in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Marshall Wace LLP increased its holdings in shares of H.B. Fuller by 9.9% in the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after purchasing an additional 26,239 shares during the last quarter. Finally, S&CO Inc. grew its stake in shares of H.B. Fuller by 0.3% in the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after buying an additional 920 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.